The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis
Abstract
Background — Recent findings suggest a causative role of infections in the pathogenesis of atherosclerosis. In hypothesizing an association between infectious agents and the development of atherosclerosis, we would expect a correlation to the extent of atherosclerosis. Moreover, this effect could be multiplied by the number of pathogens to which an individual had been exposed. Methods and Results — In 572 patients, IgG or IgA antibodies to herpes simplex virus 1 and 2, cytomegalovirus, Epstein-Barr virus, Hemophilus influenzae , Chlamydia pneumoniae , Mycoplasma pneumoniae , and Helicobacter pylori were measured. The extent of atherosclerosis was determined by coronary angiography, carotid duplex sonography, and evaluation of the ankle-arm index. Elevated IgA antibodies against C pneumoniae ( P <0.04) and IgG antibodies against H pylori ( P <0.02), cytomegalovirus ( P <0.05), and herpes simplex virus 2 ( P <0.01) were associated with advanced atherosclerosis (≥2 vascular regions), adjusted for age, sex, cardiovascular risk factors, and highly sensitive C-reactive protein. Infectious burden divided into 0 to 3, 4 to 5, and 6 to 8 seropositivities was significantly associated with advanced atherosclerosis, with an odds ratio (95% CI) of 1.8 (1.2 to 2.6) for 4 to 5 ( P <0.01) and 2.5 (1.2 to 5.1) for 6 to 8 seropositivities ( P <0.02) (adjusted). After a mean follow-up of 3.2 years, cardiovascular mortality rate was 7.0% in patients with advanced atherosclerosis and seropositive for 0 to 3 pathogens compared with 20.0% in those seropositive for 6 to 8 pathogens. Conclusions — Our results support the hypothesis that infectious agents are involved in the development of atherosclerosis. We showed a significant association between infectious burden and the extent of atherosclerosis. Moreover, the risk for future death was increased by the number of infectious pathogens, especially in patients with advanced atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Newman, A. B., Shemanski, L., Manolio, T. A., Cushman, M., Mittelmark, M., Polak, J. F., Powe, N. R., & Siscovick, D. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.538 · Cited by 871
Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 786
Relation of Helicobacter pylori infection and coronary heart disease.
Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D., Camm, A. J., & Northfield, T. C. (1994) · Heart · doi:10.1136/hrt.71.5.437 · Cited by 658
Infection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Virus-induced atherosclerosis.
Fabricant, C. G., Fabricant, J., Litrenta, M. M., & Minick, C. R. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.1.335 · Cited by 508
Chiu, B., Viira, E., Tucker, W., & Fong, I. W. (1997) · Circulation · doi:10.1161/01.cir.96.7.2144 · Cited by 307
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
Zhu, J., Quyyumi, A. A., Norman, J. E., Csako, G., Waclawiw, M. A., Shearer, G. M., & Epstein, S. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00653-0 · Cited by 298
Induction of Macrophage Foam Cell Formation by Chlamydia pneumoniae
Kalayoglu, M. V., & Byrne, G. I. (1998) · The Journal of Infectious Diseases · doi:10.1086/514241 · Cited by 275
Rupprecht, H. J., Blankenberg, S., Bickel, C., Rippin, G., Hafner, G., Prellwitz, W., Schlumberger, W., & Meyer, J. (2001) · Circulation · doi:10.1161/hc2601.091703 · Cited by 253
Self-citation
Cited by
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., et al. (2006) · Stroke · doi:10.1161/01.str.0000223048.70103.f1 · Cited by 1,368
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. J. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
The interaction of bacterial pathogens with platelets
Fitzgerald, J. R., Foster, T. J., & Cox, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1425 · Cited by 489
Infection, inflammation, height, and longevity
Crimmins, E. M., & Finch, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501470103 · Cited by 462
Autoimmune and Inflammatory Mechanisms in Atherosclerosis
Wick, G., Knoflach, M., & Xu, Q. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104644 · Cited by 431
Fliser, D., Buchholz, K., & Haller, H. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 404
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.163 · Cited by 373
O'Connor, C. M., Dunne, M. W., Pfeffer, M. A., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Fisher, M. R., Cook, T. D., & for the Investigators in the WIZARD Study (2003) · JAMA · doi:10.1001/jama.290.11.1459 · Cited by 328
Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Ishani, A., Collins, A. J., Herzog, C. A., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00414.x · Cited by 313
A study on the association between infectious burden and Alzheimer's disease
Bu, X. ‐., Yao, X. ‐., Jiao, S. ‐., Zeng, F., Liu, Y. ‐., Xiang, Y., Liang, C. ‐., Wang, Q. ‐., Wang, X., Cao, H. ‐., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12477 · Cited by 273
The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis
Hurtubise, J., McLellan, K., Durr, K., Onasanya, O., Nwabuko, D., & Ndisang, J. F. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0632-z · Cited by 255
Andraws, R., Berger, J. S., & Brown, D. L. (2005) · JAMA · doi:10.1001/jama.293.21.2641 · Cited by 235
Burden of infection and insulin resistance in healthy middle-aged men
Fernández-Real, J.-M., López-Bermejo, A., Vendrell, J., Ferri, M.-J., Recasens, M., & Ricart, W. (2006) · Diabetes Care · doi:10.2337/dc05-2068 · Cited by 106
Sun, H., & Singh, N. (2009) · Clinical Infectious Diseases · doi:10.1086/597039 · Cited by 65
Plasma myeloperoxidase is related to the severity of coronary artery disease
Düzgünçinar, Ö., Yavuz, B., Hazirolan, T., Deniz, A., Tokgözoglu, S. L., Akata, D., & Demirpençe, E. (2008) · Acta Cardiologica · doi:10.2143/ac.63.2.2029520 · Cited by 54
Vliegen, I., Herngreen, S. B., Grauls, G. E. L. M., Bruggeman, C. A., & Stassen, F. R. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.035 · Cited by 46
Haeseker, M. B., Pijpers, E., Dukers-Muijrers, N. H., Nelemans, P., Hoebe, C. J., Bruggeman, C. A., Verbon, A., & Goossens, V. J. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-30 · Cited by 46
Grąbczewska, Z., Nartowicz, E., Kubica, J., & Rość, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.02.005 · Cited by 20
Metadata
- Authors
- Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W., & Meyer, J.
- Venue
- Circulation
- Published
- 2002-01
- Volume
- 105
- Issue
- 1
- Pages
- 15-21
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2170857500
- Cited by
- 338
- References
- 21
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.